Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Leases (2022 - 2025)

Biofrontera has reported Current Leases over the past 4 years, most recently at $332000.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 39.42% year-over-year to $332000.0; the TTM value through Dec 2025 reached $332000.0, down 39.42%, while the annual FY2025 figure was $332000.0, 39.42% down from the prior year.
  • Current Leases for Q4 2025 was $332000.0 at Biofrontera, up from $307000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $701000.0 in Q2 2024 and troughed at $307000.0 in Q3 2025.
  • A 4-year average of $528750.0 and a median of $523000.0 in 2022 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: skyrocketed 42.56% in 2024 and later tumbled 54.18% in 2025.
  • Year by year, Current Leases stood at $498000.0 in 2022, then soared by 38.76% to $691000.0 in 2023, then dropped by 20.69% to $548000.0 in 2024, then tumbled by 39.42% to $332000.0 in 2025.
  • Business Quant data shows Current Leases for BFRI at $332000.0 in Q4 2025, $307000.0 in Q3 2025, and $443000.0 in Q2 2025.